Breast cancer patient treated with fulvestant

Abstract

Breast cancer is the most common cancer among Polish women. Every year around 5000 women dies due to this disease. Breast cancer is second common after lung cancer caused of death among females cancer patients. This is case report of breast cancer patient treated with neoadjuvant chemotherapy, breast amputation, radiotherapy and hormonotherapy. After 4 years due to recurrence patient underwent operation, chemotherapy and second line hormonotherapy — fulvestrant.